Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
JPMORGAN CHASE & CO
Report date May 15, 2006 · Filed May 17, 2006
Section 16 reporting ended · disclosed 2006-05-17. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Merck & Co., Inc.
Report date October 14, 2009 · Filed October 14, 2009
Section 16 reporting ended · disclosed 2009-10-14. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2003 Filed Oct 1, 2003 16:16 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantCommon Stock Equivalents · Derivative | 546.97 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000019617-03-000444 · bec299.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,242.77 Underlying: Common Stock · 546.97 shares Expires not disclosed F1 · derivative.exercise_date: Deferral of quarterly retainer, payable in cash upon termination of service as director. F1 · derivative.expiration_date: Deferral of quarterly retainer, payable in cash upon termination of service as director. Read SEC document |
| September 23, 2003 Filed Sep 24, 2003 22:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 244.64 | $16.35 Strike: $0.00 | $3,999.86 |
DisclosureSEC source: 0000310158-03-000075 · bec217.xml · derivative · entry 2 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,137.81 Underlying: Common Shares · 244.64 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include 275.00 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| September 22, 2003 Filed Sep 24, 2003 22:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 61.39 | $16.29 Strike: $0.00 | $1,000.04 |
DisclosureSEC source: 0000310158-03-000075 · bec217.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,893.17 Underlying: Common Shares · 61.39 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include 275.00 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| August 21, 2003 Filed Aug 22, 2003 20:03 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 60.68 | $16.48 Strike: $0.00 | $1,000.01 |
DisclosureSEC source: 0000310158-03-000066 · bec210.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,556.78 Underlying: Common Shares · 60.68 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| August 14, 2003 Filed Aug 15, 2003 21:34 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 62.27 | $16.06 Strike: $0.00 | $1,000.06 |
DisclosureSEC source: 0000310158-03-000061 · bec205.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,496.1 Underlying: Common Shares · 62.27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 30, 2003 Filed Aug 1, 2003 15:20 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 58.31 | $17.15 Strike: $0.00 | $1,000.02 |
DisclosureSEC source: 0000310158-03-000052 · bec184.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,433.83 Underlying: Common Shares · 58.31 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 22, 2003 Filed Jul 23, 2003 21:25 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 58.93 | $16.97 Strike: $0.00 | $1,000.04 |
DisclosureSEC source: 0000310158-03-000046 · bec158.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,375.52 Underlying: Common Shares · 58.93 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 16, 2003 Filed Jul 17, 2003 18:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 59.1 | $16.92 Strike: $0.00 | $999.97 |
DisclosureSEC source: 0000310158-03-000042 · bec125.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,316.59 Underlying: Common Shares · 59.1 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 10, 2003 Filed Jul 14, 2003 18:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 58.14 | $17.20 Strike: $0.00 | $1,000.01 |
DisclosureSEC source: 0000310158-03-000036 · bec112.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,257.49 Underlying: Common Shares · 58.14 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 02, 2003 Filed Jul 2, 2003 22:11 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 51.68 | $19.35 Strike: $0.00 | $1,000.01 |
DisclosureSEC source: 0000310158-03-000033 · bec95.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,199.35 Underlying: Common Shares · 51.68 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 12:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 513.16 | $19.00 Strike: $0.00 | $9,750.04 |
DisclosureSEC source: 0000310158-03-000028 · bec92.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,147.67 Underlying: Common Shares · 513.16 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| June 30, 2003 Filed Jul 2, 2003 16:24 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | OtherCommon Stock Equivalents · Derivative | 191.31 | $34.06 Strike: $0.00 | $6,515.06 |
DisclosureSEC source: 0000019617-03-000363 · bec267.xml · derivative · entry 2 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,527.44 Underlying: Common Stock · 191.31 shares Expires 1988-08-08 F2 · security: Common stock equivalents payable in cash upon termination of service as director. F3 · derivative.exercise_price: 1-for-1 F4 · derivative.exercise_date: This date entry is made pursuant to SEC EDGAR guidelines in effect until system modifications are implemented. F4 · derivative.expiration_date: This date entry is made pursuant to SEC EDGAR guidelines in effect until system modifications are implemented. Read SEC document |
| June 30, 2003 Filed Jul 2, 2003 16:24 UTC | JPMORGAN CHASE & CO JPM · Entity 2795 | GrantCommon Stock Equivalents · Derivative | 550.58 | $34.06 Strike: $0.00 | $18,750.00 |
DisclosureSEC source: 0000019617-03-000363 · bec267.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,336.13 Underlying: Common Stock · 550.58 shares Expires 1988-08-08 F1 · security: Deferral of quarterly retainer, payable in cash upon termination of service as director. F3 · derivative.exercise_price: 1-for-1 F4 · derivative.exercise_date: This date entry is made pursuant to SEC EDGAR guidelines in effect until system modifications are implemented. F4 · derivative.expiration_date: This date entry is made pursuant to SEC EDGAR guidelines in effect until system modifications are implemented. Read SEC document |
| June 24, 2003 Filed Jun 25, 2003 22:14 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 52.6 | $19.01 Strike: $0.00 | $999.93 |
DisclosureSEC source: 0000310158-03-000023 · bec75.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,634.51 Underlying: Common Shares · 52.6 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| June 23, 2003 Filed Jun 25, 2003 19:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 157.23 | $19.08 Strike: $0.00 | $2,999.95 |
DisclosureSEC source: 0000310158-03-000018 · bec68.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,581.91 Underlying: Common Shares · 157.23 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| June 23, 2003 Filed Dec 10, 2003 19:47 UTC Amendment | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 209.64 | $19.08 Strike: $0.00 | $3,999.93 |
DisclosureSEC source: 0000310158-03-000152 · bec306.xml · derivative · entry 1 BECHERER HANS W · CIK 0001023199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,635.1 Underlying: Common Shares · 209.64 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · shares: Corrects inadvertent clerical error in number of securities on report filed June 25, 2003 and total holdings in subsequent reports, to include 53.19 shares. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F3 · derivative.underlying_shares: Corrects inadvertent clerical error in number of securities on report filed June 25, 2003 and total holdings in subsequent reports, to include 53.19 shares. F3 · balance_after: Corrects inadvertent clerical error in number of securities on report filed June 25, 2003 and total holdings in subsequent reports, to include 53.19 shares. F6 · balance_after: Includes 0.78 additional shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, through November 26, 2003. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.